How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | STESTERIS plc | MDTMedtronic plc | TRIBTRINITY BIOTECH PLC | HBCN.IRHBCN.IR | Median of the restexcluding STE |
|---|---|---|---|---|---|
| Status | OK | OK | OK | Not found. Check the ticker, or it may not be covered by the configured data sources. | |
| Type | Company | Company | Company | — | |
| Price | $232.22▲ 10.74 (4.85%) | $96.59▲ 3.56 (3.83%) | $7.51▼ 0.24 (3.10%) | not reported | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 9.0/10 | 8.0/10 | 5.0/10 | not reported | 6.5/10 |
| Market value | $22.71B | $123.65B | $5.0M | — | |
| Revenue | $5.94B | $36.36B | $61.6M | — | |
| Profit | $782.3M | $4.80B | -$31.2M | — | |
| Revenue growthChange in sales versus the prior year. | 8.7% | 8.4% | 8.3% | — | 8.4% |
| Gross marginShare of sales left after the direct cost of producing them. | 44.2% | 65.0% | 34.8% | — | 49.9% |
| Operating marginShare of sales left after running the business, before interest and tax. | 18.6% | 17.8% | -34.4% | — | -8.3% |
| Profit marginProfit kept from each dollar of sales. | 13.2% | 13.2% | -50.7% | — | -18.8% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 16.4% | 14.9% | -7.5% | — | 3.7% |
| Return on equityProfit against the owners' stake in the company. | 10.9% | 9.7% | 88.7% | — | 49.2% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 9.5% | 6.7% | — | — | 6.7% |
| P/E ratioPrice paid per dollar of annual profit. | 29.03x | 25.76x | — | — | 25.76x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 15.24x | 15.88x | — | — | 15.88x |
| Price to book | 3.16x | 2.50x | -0.14x | — | 1.18x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.49x | 0.87x | -3.94x | — | -1.53x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 9/9 | 7/9 | 4/9 | not reported | 5.5 |
| Bankruptcy riskAltman Z-Score zone. | safe | safe | distress | not reported |
How STE compares with the others
- STE's operating margin of 18.6% is higher than the median of the other companies selected (-8.3%).
- Its revenue growth of 8.7% is in line with the median of the other companies selected (8.4%).
- It trades at a higher P/E than the other company selected: 29.0x against 25.8x.
- Its liabilities are higher relative to equity than the median of the other companies selected: 0.5x against -1.5x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.